Trials / Sponsors / Antiva Biosciences
Antiva Biosciences
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts Human Papillomavirus Infection | Phase 1 / Phase 2 | 2024-03-27 |
| Terminated | A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Ce Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | 2022-09-10 |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infec HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions, High-Grade Cervical Intraepithelial Neoplasia | Phase 1 | 2018-12-21 |
| Terminated | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection, HIV Infection | Phase 1 | 2018-12-17 |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infec HSIL, HSIL of Cervix, High-Grade Squamous Intraepithelial Lesions | Phase 1 | 2018-01-01 |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection, HIV Infection | Phase 1 | 2017-08-11 |